Higher AlphaB-Crystallin Levels Linked to Diabetic Retinopathy

Share this content:
Higher AlphaB-Crystallin Levels Linked to Diabetic Retinopathy
Higher AlphaB-Crystallin Levels Linked to Diabetic Retinopathy

WEDNESDAY, Dec. 21, 2016 (HealthDay News) -- Vitreous levels of alphaB-crystallin are significantly higher in eyes of patients with proliferative diabetic retinopathy (PDR) compared to the eyes of controls without diabetes, according to a study published online Dec. 7 in Clinical & Experimental Ophthalmology.

Wei Chen, Ph.D., from the Affiliated Hospital of Nantong University in China, and colleagues assessed vitreous samples collected before vitrectomy from 46 eyes of 46 consecutive patients with PDR and 19 patients without diabetes mellitus who had vitrectomy for idiopathic macular hole. Enzyme-linked immunosorbent assay was used to measure concentrations of alphaB-crystallin and vascular endothelial growth factor (VEGF).

The researchers found that the vitreous level of alphaB-crystallin was significantly higher in patients with PDR versus controls (P < 0.0001), as was the vitreous concentration of VEGF (P < 0.0001). Similarly, the expression levels of both alphaB-crystallin and VEGF were significantly higher in eyes with active PDR than in those with inactive PDR.

"These results suggest a significant increase of alphaB-crystallin in the vitreous fluid of patients with PDR and present a crucial association between alphaB-crystallin and VEGF with angiogenic activity in PDR," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »